212 related articles for article (PubMed ID: 25200424)
1. Ultrasound as predictor of histologic subtypes linked to recurrence in basal cell carcinoma of the skin.
Wortsman X; Vergara P; Castro A; Saavedra D; Bobadilla F; Sazunic I; Zemelman V; Wortsman J
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):702-7. PubMed ID: 25200424
[TBL] [Abstract][Full Text] [Related]
2. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
[TBL] [Abstract][Full Text] [Related]
3. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
5. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
6. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of high-resolution ultrasound in detecting invasive disease in recurrent basal cell carcinoma after nonsurgical treatment.
Hernández-Ibáñez C; Aguilar-Bernier M; Fúnez-Liébana R; Del Boz J; Blázquez N; de Troya M
Actas Dermosifiliogr; 2014 Dec; 105(10):935-9. PubMed ID: 25015637
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of High-Frequency Ultrasound in the Classification of Histologic Subtypes of Primary Basal Cell Carcinoma.
Hernández-Ibáñez C; Blazquez-Sánchez N; Aguilar-Bernier M; Fúnez-Liébana R; Rivas-Ruiz F; de Troya-Martín M
Actas Dermosifiliogr; 2017; 108(1):42-51. PubMed ID: 27720188
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
10. Scalp Basal Cell Carcinoma: Review of 2,202 Cases.
Cho M; Lee J; James CL; Marshman G; Huilgol SC
Dermatol Surg; 2016 Jul; 42(7):834-41. PubMed ID: 27243131
[TBL] [Abstract][Full Text] [Related]
11. Superficial basal cell carcinomas of the head and neck.
Mina MA; Picariello A; Fewkes JL
Dermatol Surg; 2013 Jul; 39(7):1003-8. PubMed ID: 23465089
[TBL] [Abstract][Full Text] [Related]
12. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
Armstrong LTD; Magnusson MR; Guppy MPB
J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
[TBL] [Abstract][Full Text] [Related]
14. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
[TBL] [Abstract][Full Text] [Related]
16. Association of Multiple Aggregated Yellow-White Globules With Nonpigmented Basal Cell Carcinoma.
Navarrete-Dechent C; Liopyris K; Rishpon A; Marghoob NG; Cordova M; Dusza SW; Sahu A; Kose K; Oliviero M; Rabinovitz H; Busam KJ; Marchetti MA; Chen CJ; Marghoob AA
JAMA Dermatol; 2020 Aug; 156(8):882-890. PubMed ID: 32459294
[TBL] [Abstract][Full Text] [Related]
17. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
18. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of an ultrasound system in the evaluation of skin cancers: correlation with histology.
Song WJ; Choi HJ; Lee YM; Tark MS; Nam DH; Han JK; Cho HD
Ann Plast Surg; 2014 Oct; 73(4):427-33. PubMed ID: 23903081
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
